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Background
Intact LINE-1 (L1) elements are the only non-LTR retro-
transposons encoded by the human genome known to be
capable of autonomous replication. Retrotransposition of
these elements is controlled by host-factors, including
members of the APOBEC3 family of proteins. HIV-1
encodes the accessory protein Vif, which induces the pro-
teasomal degradation of APOBECs 3F/3G. We hypothe-
sized that this would result in the induction of L1
retrotransposition events in HIV-1-infected cells.
Materials and methods
DNA copy numbers of L1PA family L1 elements were
quantified over in vitro HIV-1 infection time-courses by
qPCR. High molecular weight genomic DNA was isolated
from these samples by electrophoresis and subjected to L1
quantitation. Cells from infections were stained for HIV-
1-Gag, and sorted by FACS. DNA copy numbers of L1 ele-
ments in Gag+ and Gag- fractions were quantified. Using
targeted genome differences analysis (TGDA) we queried
HIV-1-infected cells for de novo genomic L1 Insertions. An
eGFP-reporter retrotransposition assay was used to study
the effect of HIV-1 and HIV-1-ΔVif infection of Jurkat cells
on L1 retrotransposition frequency.
Results
L1 element DNA increased over time in both total and
high-molecular weight DNA from HIV-1-infected cells,
consistently reaching 2-3 fold above baseline within 144
hours. By absolute quantitation this was determined to
represent the generation of tens of thousands of novel L1
sequences per cell. By sorting Gag+ from Gag- cells we
confirmed that this increase was primarily restricted to
HIV-1 infected cells. Using TGDA we identified de novo
LINE-1 insertions in HIV-1 infected primary CD4+ T cells.
These sequences displayed the hallmarks of L1 retrotrans-
position events including long poly(A) tracts at the inser-
tional junction, and were absent in DNA from autologous
uninfected cells. The eGFP reporter retrotransposition
assay showed an increased L1 retrotransposition fre-
quency in HIV-1 infected Jurkat cells as compared to unin-
fected controls. Infection with HIV-1 ΔVif resulted in L1
retrotransposition frequences which were substantially
less than that observed with wild-type virus, but still ele-
vated as compared to uninfected controls (36.0 +/- 1.2%
eGFP+ for wild-type infection, versus 18.4 +/- 0.5% for
HIV-1 ΔVif, and 6.3 +/- 0.7%, p < 0.0001 for either com-
parison).
Conclusion
HIV-1 infection induced high frequencies of L1 retrotrans-
position in primary CD4+ T cells. This induction was par-
tially dependent upon HIV-1-Vif. However, the observed
enhancement of retrotransposition by Vif-deleted virus
suggests the involvement of additional mechanisms. Our
findings demonstrate the largely unexplored potential for
interactions between exogenous retroviruses, such as HIV-
1, and endogenous retrotransposable elements.
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